Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 28.03 | N/A |
| PEG Ratio (TTM) | 7.51 | N/A |
| P/S Ratio (TTM) | 2.20 | N/A |
| P/B Ratio (TTM) | 3.20 | N/A |
| P/FCF Ratio (TTM) | 26.43 | N/A |
| Price to 5YR AVG Earnings Ratio | 27.46 | N/A |
| Price to 5YR AVG FCF Ratio | 36.68 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.62% | N/A |
| ROE (TTM) | 11.68% | N/A |
| Net Profit Margin (TTM) | 7.88% | N/A |
| ROIC 5YR AVG | 28.08% | N/A |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 5.84% | 269.69% | 148.95% |
| Revenue | 3.96% | 12.27% | 7.37% |
| Net Income | 5.75% | 271.30% | 149.51% |
| Cash Flow | 12.33% | 65.89% | 33.40% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.33 | N/A |
| Quick Ratio (TTM) | 1.30 | N/A |
| D/E Ratio (TTM) | 0.55 | N/A |
| Interest Coverage (TTM) | 16.80 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 2.20 | N/A |
| LTL to 5YR AVG FCF | 5.91 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.20% | N/A |